Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14526 - 14550 of 14794 in total
LY-2623091 is under investigation in clinical trial NCT02194465 (A Study of LY2623091 in Participants With High Blood Pressure).
Investigational
Matched Description: … LY-2623091 is under investigation in clinical trial NCT02194465 (A Study of LY2623091 in Participants …
Penequinine, Penehyclidine is under investigation in clinical trial NCT02644876 (Preventive Effects of Penehyclidine Hydrochloride Inhalation on Postoperative Pulmonary Complications).
Investigational
Matched Description: … Penequinine, Penehyclidine is under investigation in clinical trial NCT02644876 (Preventive Effects of
Experimental
Experimental
Experimental
AZD-5991 is under investigation in clinical trial NCT03218683 (Study of AZD5991 in Relapsed or Refractory Haematologic Malignancies.).
Investigational
Matched Description: … AZD-5991 is under investigation in clinical trial NCT03218683 (Study of AZD5991 in Relapsed or Refractory …
RO-5045337 is under investigation in clinical trial NCT01164033 (A Study of RO5045337 in Patients With Solid Tumors).
Investigational
Matched Description: … RO-5045337 is under investigation in clinical trial NCT01164033 (A Study of RO5045337 in Patients With …
GSK232802 is under investigation in clinical trial NCT00604825 (Treatment of Hot Flashes/flushes in Postmenopausal Women (WARM Study)).
Investigational
Matched Description: … GSK232802 is under investigation in clinical trial NCT00604825 (Treatment of Hot Flashes/flushes in Postmenopausal …
Buprenorphine hemiadipate is under investigation in clinical trial NCT01582347 (Transfer of Subjects From Subutex/suboxone to RBP-6300).
Investigational
Matched Description: … Buprenorphine hemiadipate is under investigation in clinical trial NCT01582347 (Transfer of Subjects …
STG-001 is under investigation in clinical trial NCT04489511 (Study of STG-001 in Subjects With Stargardt Disease).
Investigational
Matched Description: … STG-001 is under investigation in clinical trial NCT04489511 (Study of STG-001 in Subjects With Stargardt …
Tinlorafenib (PF-07284890) is a potent, selective, highly brain-penetrant, small-molecule inhibitor of BRAF V600 mutations.
Investigational
Matched Description: … Tinlorafenib (PF-07284890) is a potent, selective, highly brain-penetrant, small-molecule inhibitor of
BMS-690514 has been investigated for the treatment of Breast Cancer.
Investigational
Matched Description: … BMS-690514 has been investigated for the treatment of Breast Cancer. …
Pentavalent Antimony has been investigated for the treatment of Cutaneous Leishmaniasis.
Investigational
Matched Description: … Pentavalent Antimony has been investigated for the treatment of Cutaneous Leishmaniasis. …
PD-98059 is an inhibitor of MAP-kinase kinase activation.
Investigational
Matched Description: … PD-98059 is an inhibitor of MAP-kinase kinase activation.[A253072] …
SPG601 is being investigated for the treatment of fragile X syndrome.
Investigational
Matched Description: … SPG601 is being investigated for the treatment of fragile X syndrome. …
Experimental
Capromorelin is under investigation in clinical trial NCT00527046 (Effects Of An Oral Growth Hormone Secretagogue In Older Functionally Limited Adults).
Investigational
Matched Description: … Capromorelin is under investigation in clinical trial NCT00527046 (Effects Of An Oral Growth Hormone …
Carfentanil, C-11 is under investigation in clinical trial NCT01899170 (Towards Individualized Deep Brain Stimulation Treatment of Chronic Neuropathic Pain).
Investigational
Matched Description: … investigation in clinical trial NCT01899170 (Towards Individualized Deep Brain Stimulation Treatment of
Setogepram is under investigation in clinical trial NCT03184584 (Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome).
Investigational
Matched Description: … Setogepram is under investigation in clinical trial NCT03184584 (Open-Label Rollover Study of PBI 4050 …
Displaying drugs 14526 - 14550 of 14794 in total